Fernández-Eulate, G., Muñoz-Lopetegi, A., Ruiz, I., & Urtasun, M. (2019). Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement. BMJ Case Rep.
Stile di citazione ChicagoFernández-Eulate, Gorka, Amaia Muñoz-Lopetegi, Irune Ruiz, e Miguel Urtasun. "Vemurafenib As First-line Therapy in BRAF-V600E-mutant Erdheim-Chester Disease With CNS Involvement." BMJ Case Rep 2019.
Citazione MLAFernández-Eulate, Gorka, Amaia Muñoz-Lopetegi, Irune Ruiz, e Miguel Urtasun. "Vemurafenib As First-line Therapy in BRAF-V600E-mutant Erdheim-Chester Disease With CNS Involvement." BMJ Case Rep 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.